unvaccinated group:N/A

2 trials

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Microbiology/CUHK

Conditions

Cervical CancerInfluenza

Unknown Phase

Effectiveness of the prophylactic quadrivalent human papillomavirus vaccine in Chinese female: 10- and 15-year follow-up of the phase 3, double-blind, randomized, placebo-controlled V501-041 study

Active, not recruitingChiCTR2100052313

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeCervical Cancer

Start: 2021-10-25Updated: 2022-10-17

Generation of host genetic factor information known to associate with hospitalized severe influenza

Active, not recruitingChiCTR2400080640

Department of Microbiology/CUHKInfluenza

Start: 2024-02-12Updated: 2024-02-05

Related Papers

The 13-year long-term follow-up on the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in Chinese females vaccinated at 20–45 years of age

Human Vaccines & Immunotherapeutics2024-10-111 citations